During the past decade, Instituto Nacional de Saude conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Nacional de Saude" #1 sponsor was "Foundation for Innovative New Diagnostics, Switzerland" with 2 trials, followed by "Instituto Nacional de Saúde, Mozambique" with 2 trials sponsored, "Medicines for Malaria Venture" with 2 trials sponsored, "ANRS, Emerging Infectious Diseases" with 1 trials sponsored and "Muhimbili University of Health and Allied Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Saude" #1 collaborator was "Ludwig-Maximilians - University of Munich" with 4 trials as a collaborator, "Instituto Nacional de Saúde, Mozambique" with 3 trials as a collaborator, "National Institute for Medical Research, Tanzania" with 3 trials as a collaborator, "Centro de Investigação em Saúde de Manhiça" with 2 trials as a collaborator and "Ifakara Health Institute" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Saude" are "Diagnoses Disease" (2 trials), "Malaria" (2 trials), "Tuberculosis" (2 trials), "Covid19" (1 trials) and "HIV" (1 trials). Many other conditions were trialed in "Instituto Nacional de Saude" in a lesser frequency.

Most popular intervention types in "Instituto Nacional de Saude" are "Drug" (3 trials), "Biological" (2 trials), "Diagnostic Test" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab Injection" (1 trials), "Coartem® (artemether lumefantrine)" (1 trials), "Concentrated urine with Xpert Ultra" (1 trials), "Derma Vax Electroporation" (1 trials) and "HIVIS DNA vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Nacional de Saude" are 9 trials for "All" genders.

Currently, there are 5 active trials in "Instituto Nacional de Saude". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Instituto Nacional de Saude, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Nacional de Saude, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".